益赛普联合柳氮磺吡啶治疗强直性脊柱炎的疗效及对血清炎性因子的影响

Efficacy of YISAIPU Combined with Sulfasalazine in the Treatment of Ankylosing Spondylitis and its Effect on Serum Inflammatory Factors

目的研究益赛普(rh TNFR:Fc)联合柳氮磺吡啶(SASP)治疗强直性脊柱炎(AS)的疗效及对患者血清炎性因子的影响。方法纳入2022年1月-2023年6月吉安县人民医院收治的80例AS患者,经随机数字表法分为对照组(40例)与观察组(40例),对照组采用rh TNFR:Fc治疗,观察组在其基础上联合SASP治疗,比较两组临床疗效、症状改善情况(脊柱疼痛程度、晨僵时间)、血清炎性因子[血沉(ESR)、C反应蛋白(CRP)]、预后康复情况[Bath强直性脊柱炎疾病活动指数(BASDAI)、Bath强直性脊柱炎功能指数(BASFI)]。结果观察组治疗1、3个月的ASAS20达标率均高于对照组(P<0.05);两组治疗后脊柱疼痛程度评分下降,晨僵时间缩短,且观察组脊柱疼痛程度评分小于对照组,晨僵时间短于对照组(P<0.05);两组治疗后ESR、CRP水平低于治疗前,且观察组ESR、CRP水平低于对照组(P<0.05);两组治疗后BASDAI、BASFI评分均低于治疗前,且观察组BASDAI、BASFI评分低于对照组(P<0.05)。结论rh TNFR:Fc联合SASP治疗强直性脊柱炎效果肯定,可提高患者临床疗效,缓解其症状及炎性反应,改善预后。

Objective To study the efficacy of YISAIPU(rh TNFR:Fc)combined with sulfasalazine(SASP)in the treatment of ankylosing spondylitis(AS)and its effect on serum inflammatory factors.Methods Eighty AS patients admitted to Ji'an County People's Hospital from January 2022 to June 2023 were included and divided into control group(40 patients)and observation group(40 patients)by random number table method.The control group was treated with rh TNFR:Fc,and the observation group was treated with SASP on the basis of rh TNFR:Fc.The clinical efficacy,symptom improvement(spinal pain degree,morning stiffness time),serum inflammatory factors[erythrocyte sedimentation rate(ESR),C-reactive protein(CRP)],prognosis and rehabilitation[Bath Ankylosing Spondylitis Disease Activity Index(BASDAI),Bath Ankylosing Spondylitis Functional Index(BASFI)]were compared between the two groups.Results The ASAS20 compliance rate of the observation group at 1 and 3 months of treatment was higher than that of the control group(P<0.05).After treatment,the score of spinal pain in the two groups decreased,and the time of morning stiffness was shortened,while the score of spinal pain in the observation group was lower than that in the control group,and the time of morning stiffness was shorter than that in the control group(P<0.05).The levels of ESR and CRP in the two groups after treatment were lower than those before treatment,and the levels of ESR and CRP in the observation group were lower than those in the control group(P<0.05).After treatment,the BASDAI and BASFI scores of the two groups were lower than those before treatment,and the BASDAI and BASFI scores of the observation group were lower than those of the control group(P<0.05).Conclusion rh TNFR:Fc combined with SASP is effective in the treatment of ankylosing spondylitis,which can improve the clinical efficacy of patients,relieve their symptoms and inflammatory reactions,and improve the prognosis.